GMP BIO Co.,LTD

R&D

Cell therapy
Immune regulatory T cell VT301	Technology transfer completed (Kyunghee university) Completed Pre-clinical of Chemon (KOSDAQ-Listed Company), a domestic GLP company Australian Clinic Phase 1 and Phase 2a will be entered simultaneously U.S. Clinical Phase 1 and Phase 2a will be entered simultaneously Under IND review of the Korea Clinical Phase 1

Natural product medicine
Depressive VT011	MFDS individually-approved functional foodItem authorization in progress
Dementia VT012	Clinical Phase 2 completed (Korea's Ministry of Food and Drug Safety(MFDS)) Clinical Phase 2b/3 in progress
Chronic obstructive pulmonary disease(COPD) VT014	Acute upper respiratory infection: Clinical Phase 3 completed, Item authorization in progress COPD : Clinical Phase 2 costs 12 Billion, Clinical Phase 3 Costs 200 Billion estimate
Alopecia and Depilation VT015	Preclinical efficacy completedHuman application test in progress

Health functional food
Regulation of blood glucose Health functional food VT021	individually-approved health functional food item authorization (2010-33)